The Innovation Gateway
The Innovation Gateway is a dedicated life science incubator at the centre of The London Cancer Hub in Sutton, South London - one of the UK’s leading locations for cancer research and treatment. It offers fully fitted laboratory and office space tailored to early-stage and scaling life science and MedTech companies.
Designed to support businesses as they grow, the Innovation Gateway combines flexible lab and workspace with shared facilities and infrastructure. Tenants benefit from immediate access to a collaborative ecosystem, with direct connections to the scientific expertise, research capabilities and clinical insight of The Institute of Cancer Research (ICR) and The Royal Marsden NHS Foundation Trust.
Innovation Gateway is managed on behalf of the London Cancer Hub partnership by Populate, with space available for organisations looking to accelerate innovation in oncology and related health-tech fields.
Why Partner here?
- Strategic location within The London Cancer Hub, adjacent to the world-class Centre for Cancer Drug Discovery and clinical services.
- Flexible, fitted lab and office space suitable for early stage and growing teams.
- Collaboration with leading scientists & clinicians - opportunity to connect with 280+ researchers at ICR and clinical partners.
- Shared infrastructure & networks across the District, including Core Research Facilities, seminars and community events.
- Access to wider support ecosystem - from business services to investor engagement and future space within the expanding London Cancer Hub district.
Current Occupiers & Community
The Innovation Gateway has attracted an energetic mix of life science innovators advancing cancer research, diagnostics and therapeutic technologies. Current occupiers include:
- Kindling Bio - developing gene therapy solutions focused on childhood cancers.
- Beckman Coulter Diagnostics - building cutting-edge biomedical testing systems for clinical decision support.
- Curesponse - harnessing functional profiling techniques to personalise cancer treatment, collaborating closely with academic partners.
- Eliptica - transforming proteomics into routine clinical practice using high-throughput biochemistry and machine learning.
- Vesynta - data-guided precision treatment dosing technologies.
- ExoNostic - recently joined to expand its oncology R&D footprint.
This growing ecosystem is creating a vibrant community where ideas are exchanged and collaborations flourish, supported by proximity to leading research and clinical teams.
The Vision
The Innovation Gateway is a cornerstone of the London Cancer Hub’s wider ambition to establish a world-leading centre for oncology innovation and life science commercialisation. With planning consent now secured for a significant expansion of laboratory, clinical and research space across the District, the Innovation Gateway provides an early-stage launchpad for companies that will shape the future of cancer science and treatment.
For more information about the space, please contact [email protected].
